CompletedNot Applicable

Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study

United States39 participantsStarted 2022-11-09

Plain-language summary

This is a pilot evaluation of a patient-centered intervention that enables providers to support men on active surveillance to maximize adherence. Conducted in urology practices, this pilot will measure key patient-reported, provider-reported, and implementation outcomes. Successful completion of this work will inform a subsequent multi-center effectiveness-implementation hybrid design trial and ultimately will improve low-risk cancer management by effectively engaging Primary Care Physicians (PCPs) in care delivery.

Who can participate

Age range55 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Patient Inclusion Criteria: * 55 years old or older * Men diagnosed with low-risk prostate cancer currently on active surveillance * Men who identify having a primary care provider * Access and ability to use the Internet Patient Exclusion Criteria: * Men who are unable to read and/or speak English * Men with impaired decision-making capacity (such as with a diagnosis of dementia or memory loss) PCP Inclusion Criteria: * Identified by patient on baseline survey as their PCP Urologist and Clinic Staff Inclusion Criteria: * Clinicians or staff at a participating urology clinic, including but not limited to MDs, APPs, and nurses

What they're measuring

Feasibility - Recruitment

Timeframe: up to 9 months

Feasibility - Uptake

Timeframe: up to 6 months

Acceptability - Mean Satisfaction Scores

Timeframe: up to 4 months

Trial details

NCT IDNCT05764005

SponsorUniversity of Michigan Rogel Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-03-11

Results submitted2025-07-29

View on ClinicalTrials.gov More Prostate Cancer trials